StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Rajesh Satpute

BUYZydus Lifesciences Limited

byRajesh SatputeHorizon: NA (inferred Swing (≤2wk))23 Sept 2026via CNBC Awaaz.

Entry₹1,173Inferred
Target₹1,200
Total upside +2.30% (call closed)
Stop loss₹1,158-1.28% risk
Exit₹1,15823 Sept 2026, 1:10 pm
Stop-loss hit-1.28%
Follow Rajesh Satpute for new calls(31% target hit, 160 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 2 active Swing calls on ZYDUSLIFESee 276 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 23 Sept 2026
4 supporting0 opposing
Supports the BUY call (4)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·22 Sept · yesterday

Bernstein bets on this drugmaker for 28% upside citing a key value driver for the future

NewsCnbc-Tv18·18 Sept · 5d ago

(opens in new tab)

India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth

NewsNdtv-Profit·9 Sept · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·12 Aug · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.